Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Diarylmethylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116178219B reveals metal-free catalytic route. Enables cost reduction in pharmaceutical intermediate manufacturing with high enantioselectivity.